Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Halozyme Therapeutics Inc

+ Add to Watchlist


17.3700 USD 0.3100 1.75%

As of 15:06:52 ET on 05/29/2015.

Company Profile for Halozyme Therapeutics Inc (HALO)

Halozyme Therapeutics, Inc. is a biopharmaceutical company developing products for the diabetes, cancer, dermatology and drug delivery markets. The Company's platform technology is based on recombinant human hyaluronidase plus additional enzymes. Halozyme applies its technology to its proprietary programs and to partnerships with pharmaceutical companies.

Contact Information

Halozyme Therapeutics Inc

11388 Sorrento Valley Road
San Diego, CA 92121
United States
Phone: 1-858-794-8889
Fax: 1-858-259-2539

Key Executives for Halozyme Therapeutics Inc (HALO)

Helen I TorleyPresident/CEOAthena CountouriotisChief Medical Officer
Harry J LeonhardtSenior VP/Chief Compliance OfcrDavid A RamsayVP/CFO
H Michael Shepard "Mike"VP/Chief Scientific OfficerJames S Mazzola "Jim"VP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil